Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Septrin 80 mg/400 mg per ampoule, concentrate for solution for infusion.
Pharmaceutical Form |
---|
Concentrate for Solution for Infusion. Clear faintly yellow to brown solution. The pH of the solution is in the range 9.6 to 10.5. |
Each 5 ml ampoule contains 80 mg trimethoprim and 400 mg sulfamethoxazole.
Excipients with known effect: Contains 38.25 mg of sodium per 5 ml ampoule (inclusive of sodium metabisulphite E 223), 0.5 mg ethanol (alcohol) per 5 ml ampoule and 2.25 g of propylene glycol (E 1520) per 5ml ampoule.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Sulfamethoxazole |
Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. |
|
Trimethoprim |
Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. |
List of Excipients |
---|
Propylene glycol |
5ml Type 1, clear-neutral glass ampoule.
Pack size: Box of 10x5ml ampoules.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PA1691/010/005
Date of first authorisation: 14th November 1975
Date of last renewal: 14th November 2005
Drug | Countries | |
---|---|---|
SEPTRIN | Australia, Spain, Ireland, Malta, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.